Literature DB >> 12047327

Accuracy of office-based immunoassays for the diagnosis of Helicobacter pylori infection in children.

Andrew S Day1, Philip M Sherman.   

Abstract

BACKGROUND: Rapid non-invasive diagnostic tests that can reliably document the presence or absence of Helicobacter pylori infection are urgently required. The aim of this study was to determine the accuracy of two immunoassays (Flex-Sure and MedMira), developed for use outside the laboratory setting by practitioners, in the setting of a low prevalence of H. pylori infection.
METHODS: Serum samples collected in four previous studies (n = 349) were employed to detect the presence of H. pylori-specific immunoglobulin G, compared to previous results obtained using endoscopic biopsies, serology, flow cytometry, and urease breath testing. Serum samples included 52 obtained from adults (parents and grandparents of symptomatic children), 123 sera collected from children and adolescents undergoing diagnostic upper endoscopy for upper gastrointestinal tract symptoms, and 174 samples drawn from children in the primary care setting with or without recurrent abdominal pain.
RESULTS: Overall, 16% of subjects were infected by the gastric pathogen. Both the specificity (%) and negative predictive value (%) of the two tests were high (FlexSure: 91 and 92; Medmira: 97 and 94, respectively). In adults, both tests also demonstrated high sensitivity (83% and 86%) and positive predictive values (79% and 83%, respectively). However, in children where the prevalence of infection was 12% (37 of 297 subjects), the sensitivity (59% and 71%) and positive predictive values (55% and 88%, respectively) of the immunoassays were lower.
CONCLUSIONS: These findings indicate that, in the setting of a low prevalence of H. pylori infection, the MedMira office-based test provides satisfactory results and utility. However, the low positive-predictive value of the FlexSure kit may limit applicability of this test in children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047327     DOI: 10.1046/j.1523-5378.2002.00082.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  7 in total

Review 1.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

2.  Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 3.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 4.  Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009.

Authors:  Jeannette Guarner; Nicolas Kalach; Yoram Elitsur; Sibylle Koletzko
Journal:  Eur J Pediatr       Date:  2009-07-18       Impact factor: 3.183

5.  Helicobacter pylori infection in children.

Authors:  Shaman Rajindrajith; Niranga M Devanarayana; Hithanadura Janaka de Silva
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

Review 6.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

7.  Antibody-based detection tests for the diagnosis of Helicobacter pylori infection in children: a meta-analysis.

Authors:  Yelda A Leal; Laura L Flores; Laura B García-Cortés; Roberto Cedillo-Rivera; Javier Torres
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.